Adipo Therapeutics
PrivateLast Round
Seed
Jan 31, 2024
Total Funding Raised
$4.2M
Company Overview
Adipo Therapeutics is a privately held, late-stage preclinical biopharmaceutical company developing a novel treatment for obesity and Type 2 diabetes. Founded in 2016 by Purdue University professor Meng Deng, the company's core technology involves polymer-based, Notch-inhibiting nanoparticles that are injected into white adipose tissue to convert it into energy-burning brown or beige fat. This process, known as "browning," aims to increase the body's energy expenditure, leading to weight loss, improved insulin sensitivity, and better metabolic balance without requiring a reduction in calorie intake. The company's lead asset, ADPO-002, has shown promise in preclinical studies and is being developed as a potential weekly treatment. Adipo Therapeutics is backed by investors including Purdue Research Foundation, Elevate Ventures, and VisionTech Partners, and is working towards securing Series A funding for human clinical trials.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Adipo Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Adipo Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 31, 2024 | ||||
| Series A | Nov 7, 2023 | ||||
| Seed | Apr 11, 2023 | ||||
| Grant | Sep 13, 2018 |
Key People
Founding team and executive leadership
Adipo Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Purdue Research Foundation | Seed |
| Elevate Ventures | Seed |
| NIH RADx | Grant |
| VisionTech Partners | Seed |
| IU Ventures | Seed |
| Purdue Strategic Ventures | Seed |
Adipo Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Adipo Therapeutics's valuation, stock price, and market status.
